Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a wireless ANNE One vital-sign device array to reduce bedside vital-sign measurement time

Official title: Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity: A Randomized Controlled Trial

Run by Northwestern University · NCT06995742 · Data updated 2026-11-12

This trial will see if using a wireless Bluetooth ANNE One vital-sign device array reduces the time staff spend obtaining and charting vital signs for adult inpatients on a general medical floor.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment270 (estimated)
SponsorNorthwestern University
Academic / other
Locations2 sites (Chicago, Illinois and 1 other locations)
StatusRecruiting
StartedJune 2, 2025
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedJune 5, 2025
Trial IDNCT06995742 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult English-speaking inpatients admitted to Northwestern Memorial Hospital's Feinberg Unit 16 West who are not in isolation and are not pregnant, incarcerated, or hospital employees/students.

Probably not a fit

Patients who are non-English speakers, under isolation precautions, pregnant, incarcerated, or hospital employees/students are excluded and would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled time-motion trial compares use of an ANNE One Bluetooth vital-sign device array to routine bedside vital-sign measurement on a general medical floor (Feinberg Unit 16 West) at Northwestern Memorial Hospital. Adult inpatients on that unit who meet inclusion criteria are randomized to either the wireless device arm or standard vital-sign rounds. Observers will measure time spent obtaining and documenting vital signs as the primary outcome and collect secondary outcomes including sleep quality, provider behavior (interruptions and workflow), and patient satisfaction. Exclusion criteria include non-English primary language, isolation status, pregnancy, incarceration, and hospital employees or students.

Why it matters

Potential benefit: If successful, the device could reduce nursing time spent on vital-sign collection, decrease nighttime interruptions, and improve inpatient sleep and satisfaction.

How similar studies have gone: Previous studies of wireless vital-sign monitoring and time-motion analyses have sometimes shown reduced staff interruptions and improved sleep, but results vary and remain limited in inpatient randomized trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inpatients admitted to Northwestern Memorial Hospital, Feinberg Unit 16 West.

Exclusion Criteria:

* Primary language other than English, under isolation status, pregnant patients, prisoners, employees or students of the hospital or Northwestern University.

Where it's running

  • Feinberg 16 West, Northwestern Memorial Hospital
    Chicago, Illinois, United States
    Recruiting
  • Northwestern Memorial Hospital
    Chicago, Illinois, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Gregory (Randy) R Smith Jr, MD MS — Northwestern University
  • Study coordinator: Gregory (Randy) R Smith Jr, MD MS
  • Email: g.smith@nm.org
  • Phone: 312-926-5893

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.